The Digital
Revolution Meets
The Human Brain
= Pervasive
Neurotech
The team behind the new Pervasive
Neurotechnology report
Alvaro Fernandez
Editor-In-Chief
Nikhil Sriraman
IP Analyst
Brian Gurewitz
Technology Analyst
Olivier Oullier
Science Advisor
Today’s Agenda
 1-1.20pm ET: Five Key Trends Driving
Neurotechnology to Become Pervasive
 1.20-1.40pm ET: How Nielsen, Advanced
Neuromodulation Systems, Medtronic,
Microsoft and Brainlab emerged as
leading IP Holders
 1.40-2pm ET: Q&A
Five key trends and insights
1. Exponential growth since 2010, close to/ supporting
commercialization
2. Large companies developing significant portfolios,
often under the radar
3. Evolution from invasive to pervasive  impact on
medicine, health, entertainment and business
4. Multi-sensor, multi-variable analysis and use of data
(EEG, eye-tracking, heart rate, computer use,
patient…)
5. Aggressive “build” AND strategic/ tactical “buy”
Today’s Agenda
 1-1.20pm ET: Five Key Trends Driving
Neurotechnology to Become Pervasive
 1.20-1.40pm ET: How Nielsen, Advanced
Neuromodulation Systems, Medtronic,
Microsoft and Brainlab emerged as
leading IP Holders
 1.40-2pm ET: Q&A
How we identified the population of
non-invasive neurotech patent filings
4K+ US non-invasive
neurotech patents
10K+ GLOBAL pubs
yielded w/ similar
process
How we assessed patent portfolios
The SharpBrains’ IP Strength Index:
Quantity + Quality
Volume + Relevance Fwd Cites + Scope + Key Patents
IP portfolio strength of 800+ organizations assessed
via SharpBrains Index (Report includes detailed
profiles of top 30, and ranks top 100)
How the Leading IP Holders emerged
#1: Nielsen
(NYSE:NLSN)
#1: Nielsen
(NYSE:NLSN)
#2: Advanced Neuromodulation Systems
(St Jude Medical -- NYSE: STJ)
#3: Medtronic
(NYSE:MDT)
#4: Microsoft
(NASDAQ:MSFT)
#4: Microsoft
(NASDAQ:MSFT)
#5: Brainlab
206-page report includes
 Chapter I. Scoping the Opportunity
 Chapter II. The State of Pervasive
Neurotechnology Patents
 Chapter III. The Patent Holders:
Ranking of Top 100 Assignees, and
Detailed Profiles of 30 Leaders
 Chapter IV. Analysis of 50 key Active
Patents
 Check out the full Table of
Contents & Figures

Pervasive Neurotechnology: The Digital Revolution Meets the Human Brain

  • 1.
    The Digital Revolution Meets TheHuman Brain = Pervasive Neurotech
  • 2.
    The team behindthe new Pervasive Neurotechnology report Alvaro Fernandez Editor-In-Chief Nikhil Sriraman IP Analyst Brian Gurewitz Technology Analyst Olivier Oullier Science Advisor
  • 3.
    Today’s Agenda  1-1.20pmET: Five Key Trends Driving Neurotechnology to Become Pervasive  1.20-1.40pm ET: How Nielsen, Advanced Neuromodulation Systems, Medtronic, Microsoft and Brainlab emerged as leading IP Holders  1.40-2pm ET: Q&A
  • 11.
    Five key trendsand insights 1. Exponential growth since 2010, close to/ supporting commercialization 2. Large companies developing significant portfolios, often under the radar 3. Evolution from invasive to pervasive  impact on medicine, health, entertainment and business 4. Multi-sensor, multi-variable analysis and use of data (EEG, eye-tracking, heart rate, computer use, patient…) 5. Aggressive “build” AND strategic/ tactical “buy”
  • 12.
    Today’s Agenda  1-1.20pmET: Five Key Trends Driving Neurotechnology to Become Pervasive  1.20-1.40pm ET: How Nielsen, Advanced Neuromodulation Systems, Medtronic, Microsoft and Brainlab emerged as leading IP Holders  1.40-2pm ET: Q&A
  • 13.
    How we identifiedthe population of non-invasive neurotech patent filings 4K+ US non-invasive neurotech patents 10K+ GLOBAL pubs yielded w/ similar process
  • 14.
    How we assessedpatent portfolios The SharpBrains’ IP Strength Index: Quantity + Quality Volume + Relevance Fwd Cites + Scope + Key Patents
  • 15.
    IP portfolio strengthof 800+ organizations assessed via SharpBrains Index (Report includes detailed profiles of top 30, and ranks top 100) How the Leading IP Holders emerged
  • 16.
  • 17.
  • 18.
    #2: Advanced NeuromodulationSystems (St Jude Medical -- NYSE: STJ)
  • 19.
  • 20.
  • 21.
  • 22.
  • 24.
    206-page report includes Chapter I. Scoping the Opportunity  Chapter II. The State of Pervasive Neurotechnology Patents  Chapter III. The Patent Holders: Ranking of Top 100 Assignees, and Detailed Profiles of 30 Leaders  Chapter IV. Analysis of 50 key Active Patents  Check out the full Table of Contents & Figures